PNC Financial Services Group
TPST icon

PNC Financial Services Group’s Tempest Therapeutics TPST Stock Holding History

PNC Financial Services Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Hold
0
– -$1K – 4270
2016
Q2 		– Hold
0
– – – 4380
2016
Q1 		– Hold
0
– – – 4389
2015
Q4 		– Hold
0
– – – 4353
2015
Q3 		– Sell
-12
Closed -$808K – 4495
2015
Q2 		$976K Sell
12
-1
-8% -$91.6K ﹤0.01% 1280
2015
Q1 		$1.28M Buy
13
+7
+117% +$932K ﹤0.01% 1151
2014
Q4 		$719K Buy
+6
New +$439K ﹤0.01% 1355

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PNC Financial Services Group's TPST Position: Q3 2016 in Review

PNC Financial Services Group held its Tempest Therapeutics (TPST) position steady in Q3 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4270.

PNC Financial Services Group first reported a position in TPST in Q4 2014 and has held it in 3 quarters since. The position peaked at $1.28M in Q1 2015. 80 funds tracked by Wall St. Rank hold TPST as of Q3 2016.

  • PNC Financial Services Group held 0 shares of Tempest Therapeutics worth $0 as of Q3 2016.
  • PNC Financial Services Group left its Tempest Therapeutics share count unchanged in Q3 2016.
  • Tempest Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2016, its #4270 holding.
  • PNC Financial Services Group first reported a position in Tempest Therapeutics in Q4 2014 and has held it in 3 quarters since.
  • PNC Financial Services Group's Tempest Therapeutics position peaked at $1.28M in Q1 2015.
  • 80 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.